Mahalaxmi Fab. (MFML)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.33 is deep value: ₹25 against book value ₹75.69
• Promoter holding of 64.8% aligns management interests with minority shareholders
• Debt-to-equity of 0.66 is manageable and not excessively leveraged
• Piotroski F-score of 6/9 suggests some financial health despite weak profits

Concerns

• ROE is negative at -3.39% and the latest quarter shows a net loss of ₹1 crore
• Sales declined by 19.48%, indicating a shrinking business
• ROCE of 0.13% is far below acceptable return on invested capital
• Profit growth of 253.27% is misleading due to the low or negative earnings base

AI Analysis

At ₹25, Mahalaxmi Fab trades at just one-third of its book value of ₹75.69. That is enough to catch any Graham-style investor's attention. But a cheap price only matters if the underlying business can generate returns from those assets. Right now, it is not doing so. ROE is negative at -3.39%, ROCE is a negligible 0.13%, and the latest quarter shows a net loss of ₹1 crore on sales of ₹32 crore. Sales have also declined nearly 19.5% year-on-year. This is not a growing business; it is a shrinking one. The reported profit growth of 253% is a low-base illusion and tells me nothing about sustainable earning power. The Piotroski F-score of 6 is mildly encouraging from a financial-structure standpoint, but it does not overcome the absence of real profits. Debt-to-equity of 0.66 is manageable, and promoter holding at 64.8% is reassuring—promoters have skin in the game. Still, with no dividend, the only way I earn is through an eventual re-rating of the assets or a genuine operational turnaround. At ₹25 versus book value of ₹75.69, the market is skeptical. I have to ask: are those assets productive or just on paper? With ROCE barely above zero, the company is not converting its capital into shareholder wealth. This is a classic asset play, not a fast grower or a stalwart. Buying a cheap business that earns nothing can be a value trap unless a catalyst appears. I would wait for evidence that book value is real and can be unlocked through better operations, asset sales, or improved capital allocation. Until then, the margin of safety rests on the balance sheet, not the income statement.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer